Evidence map›Paper›PMID 28978555›Full record

ArticleBMJ (Clinical research ed.)2017

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.

Courtney Davis, Huseyin Naci, Evrim Gurpinar, Elita Poplavska, Ashlyn Pinto, Ajay Aggarwal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 238 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
238citing papers in PubMed, 15 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

238 citing papers in PubMed, 15 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. The requirements of a specialist breast centre.Breast (Edinburgh, Scotland) · 2020
    Guideline
  14. Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

178 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Courtney DavisDepartment of Global Health and Social Medicine, King's College London, London WC2R 2LS, UK courtney.davis@kcl.ac.uk.
Huseyin NaciLSE Health, Department of Health Policy, London School of Economics and Political Science, London, UK.
Evrim GurpinarLSE Health, Department of Health Policy, London School of Economics and Political Science, London, UK.
Elita PoplavskaFaculty of Pharmacy, Riga Stradins University, Riga, Latvia.
Ashlyn PintoLSE Health, Department of Health Policy, London School of Economics and Political Science, London, UK.
Ajay AggarwalDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Department of Health DRF-2014-07-064
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsDrug ApprovalNeoplasmsQuality of LifeCohort StudiesEuropeHumansMedical OncologyOutcome Assessment, Health CareRetrospective StudiesSurvival AnalysisAntineoplastic Agents

Identifiers

PMID28978555
PMCPMC5627352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.